BIT 6.67% 3.2¢ biotron limited

Based on the very limited data available from the article,...

  1. 486 Posts.
    lightbulb Created with Sketch. 180
    Based on the very limited data available from the article, pembrolizumab looks like a potentially perfect drug to pair with BIT225.
    With pembrolizumab strengthening the T cells and BIT225 unmasking HIV, it looks like a winning combination.
    Let us hope their Trial goes well. With it underway at this time alongside Biotron's trials, their timing is impeccable.

    I would like to also thank the Americans for scaring out the weak hands with their financial news, as I managed to pick up a nice parcel during the dip.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.2¢
Change
0.002(6.67%)
Mkt cap ! $28.87M
Open High Low Value Volume
3.1¢ 3.3¢ 3.1¢ $13.79K 424.2K

Buyers (Bids)

No. Vol. Price($)
1 329429 3.2¢
 

Sellers (Offers)

Price($) Vol. No.
3.4¢ 100000 1
View Market Depth
Last trade - 15.51pm 26/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.